ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 347

Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases

Na Sui1, Jian Zhu2 and Fei Sun1, 1Chinese PLA General Hospital, Beijing, China, 2Rheumatology, Chinese PLA General Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: inflammatory back pain, Mimickers, osteo-anabolics and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To study and summarize the clinical features of tumor-induced osteomalacia(TIO) misdiagnosed as spondyloarthritis(SpA), aiming to explore the reasons of misdiagnosis and raise the correctness of TIO diagnosis.

Methods: A total of 18 TIO patients misdiagnosed as SpA from March 2002 to January 2016 in Department of Rheumatology of Chinese PLA General Hospital were enrolled. The clinical manifestations, laboratory examinations data, imaging features, Localization of tumors and histological characteristics were analyzed.

Results: 18 patients were included (11 males and 7 females) with a median age of 33 years (range 19–60). The mean disease duration was 3.8 years (range 0.17 to 20 years). All patients presented with persistent low back pain. The pain could not be relieved by rest or exercise, all patients had a history of taking nonsteroidal anti-inflammatory drugs and showed no obviously improvement. The inflammatory markers such as erythrocyte sedimentation rate and C-reactive protein were usually normal. The level of serum calcium was normal or slightly lower, nevertheless, all patients had hypophosphatemia and increased level of alkaline phosphatase. Sacroiliac joint lesions were found in X-ray, CT or MRI, however the lesions in sacrum or ilium were predominant rather than in joints. Abnormal bone imaging in ribs, long bones and soft tissues in addition to joints could be detected by bone scintigraphy. And the technetium-99m octreotide scintigraphy (Figure 1a) was completed to detect the causative neoplasms, then targeted images with radiographs (Figure 1b), CT or MRI were used for further localization of the tumors. Successful localization of tumors was followed by surgical resection (13 of these 18 patients) and analysis by pathology studies. The pathology results indicated that the majority (46.2 %,6 of 13) were characterized as phosphaturic mesenchymal tumors (PMTs). After tumor resection, serum phosphorus levels normalized in all 13 surgical patients after a mean of 16 days (range 3-57 days), and Clinical symptoms were alleviated within 3 months (Figure 2).

Conclusion: TIO can be easily misdiagnosed as SpA because of the atypical clinical features and imaging changes of sacroiliac joint, however, the laboratory findings and response to the NSAIDs of the two conditions are different. Considering the complete surgical resection leading to normalization of parameters in laboratory tests and relief of symptoms of TIO patients, prompt diagnosis and surgical treatment is extremely essential. Comprehensive laboratory examinations and the technetium-99m octreotide scintigraphy can contribute to the timely diagnosis of TIO.

 


Disclosure: N. Sui, None; J. Zhu, None; F. Sun, None.

To cite this abstract in AMA style:

Sui N, Zhu J, Sun F. Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-analysis-of-tumor-induced-osteomalacia-misdiagnosed-as-spondyloarthritis-a-report-of-18-cases/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-analysis-of-tumor-induced-osteomalacia-misdiagnosed-as-spondyloarthritis-a-report-of-18-cases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology